 2. Tumor histology consistent with one of the following: In Part 1, Dose Escalation - melanoma, NSCLC, ovarian cancer including fallopian tube carcinoma, or sarcoma any subtype. In Part 2, Patient Expansion - NSCLC, ovarian cancer including fallopian tube carcinoma, or the sarcoma subtypes, synovial sarcoma or myxoidround cell liposarcoma 